Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Amplifications of DNA primase 1 (PRIM1) in human osteosarcoma.
Yotov WV, Hamel H, Rivard GE, Champagne MA, Russo PA, Leclerc JM, Bernstein ML, Levy E. Yotov WV, et al. Among authors: hamel h. Genes Chromosomes Cancer. 1999 Sep;26(1):62-9. doi: 10.1002/(sici)1098-2264(199909)26:1<62::aid-gcc9>3.0.co;2-f. Genes Chromosomes Cancer. 1999. PMID: 10441007
Regulatory challenges with biosimilars: an update from 20 countries.
Kang HN, Thorpe R, Knezevic I, Casas Levano M, Chilufya MB, Chirachanakul P, Chua HM, Dalili D, Foo F, Gao K, Habahbeh S, Hamel H, Kim GH, Perez Rodriguez V, Putri DE, Rodgers J, Savkina M, Semeniuk O, Srivastava S, Tavares Neto J, Wadhwa M, Yamaguchi T. Kang HN, et al. Among authors: hamel h. Ann N Y Acad Sci. 2021 May;1491(1):42-59. doi: 10.1111/nyas.14522. Epub 2020 Nov 21. Ann N Y Acad Sci. 2021. PMID: 33222245 Free PMC article.
WHO implementation workshop on guidelines on procedures and data requirements for changes to approved biotherapeutic products, Seoul, Republic of Korea, 25-26 June 2019.
Wadhwa M, Kang HN, Jivapaisarnpong T; WHO implementation workshop on guidelines on procedures and data requirements for changes to approved biotherapeutic products; Andalucia LR, Blades CDRZ, Casas Levano M, Chang W, Chew JY, Chilufya MB, Chirachanakul P, Cho HG, Cho YO, Choi KM, Chong S, Chua HM, Farahani AV, Gencoglu M, Ghobrial MRW, Guha P, Gutierrez Lugo MT, Ha SB, Habahbeh S, Hamel H, Hong Y, Iarutkin A, Jang H, Jayachandran R, Jivapaisarnpong T, Kang HN, Kim DY, Kim GH, Kim Y, Kwon HS, Larsen J, Lee AH, Lee J, Medvedeva K, Munkombwe Z, Oh I, Park J, Park J, Putri DE, Rodgers J, Ryu S, Savkina M, Schreitmueller T, Semeniuk O, Seo M, Shin YI, Shin J, Srivastava S, Song H, Song S, Tavares Neto J, Wadhwa M, Yamaguchi T, Youn HD, Yun M. Wadhwa M, et al. Among authors: hamel h. Biologicals. 2020 May;65:50-59. doi: 10.1016/j.biologicals.2019.12.008. Epub 2020 Jan 17. Biologicals. 2020. PMID: 31959504
Antimicrobial resistance of Helicobacter pylori in Germany, 2015 to 2018.
Bluemel B, Goelz H, Goldmann B, Grüger J, Hamel H, Loley K, Ludolph T, Meyer J, Miehlke S, Mohr A, Tüffers K, Usadel H, Wagner S, Wenzel H, Wiemer L, Vorreiter J, Eisele B, Hofreuter D, Glocker EO. Bluemel B, et al. Among authors: hamel h. Clin Microbiol Infect. 2020 Feb;26(2):235-239. doi: 10.1016/j.cmi.2019.06.007. Epub 2019 Jun 15. Clin Microbiol Infect. 2020. PMID: 31212078 Free article.
WHO informal consultation on development of guidelines on procedures and data requirements for changes to approved biotherapeutic products, Seoul, Republic of Korea, 27-28 April 2017.
Wadhwa M, Kang HN, Hamel H, Jivapaisarnpong T; following participants of the WHO informal consultation on development of guidelines on procedures and data requirements for changes to approved biotherapeutic products. Wadhwa M, et al. Among authors: hamel h. Biologicals. 2018 Mar;52:83-91. doi: 10.1016/j.biologicals.2017.12.002. Epub 2017 Dec 27. Biologicals. 2018. PMID: 29289489
42 results